Literature DB >> 20951821

Novel cord blood transplant therapies.

Elizabeth J Shpall1, Catherine M Bollard, Claudio Brunstein.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20951821      PMCID： PMC4213144          DOI： 10.1016/j.bbmt.2010.10.004

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  29 in total

1.  Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy.

Authors:  M C Jensen; L J N Cooper; A M Wu; S J Forman; A Raubitschek
Journal:  Cytotherapy       Date:  2003       Impact factor: 5.414

2.  Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Authors:  Lisa Marie Serrano; Timothy Pfeiffer; Simon Olivares; Tontanai Numbenjapon; Jennifer Bennitt; Daniel Kim; David Smith; George McNamara; Zaid Al-Kadhimi; Joseph Rosenthal; Stephen J Forman; Michael C Jensen; Laurence J N Cooper
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

3.  Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells.

Authors:  S N Robinson; J Ng; T Niu; H Yang; J D McMannis; S Karandish; I Kaur; P Fu; M Del Angel; R Messinger; F Flagge; M de Lima; W Decker; D Xing; R Champlin; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2006-02       Impact factor: 5.483

4.  Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.

Authors:  Dongxia Xing; Alan G Ramsay; John G Gribben; William K Decker; Jared K Burks; Mark Munsell; Sufang Li; Simon N Robinson; Hong Yang; David Steiner; Nina Shah; John D McMannis; Richard E Champlin; Chitra Hosing; Patrick A Zweidler-McKay; Elizabeth J Shpall; Catherine M Bollard
Journal:  J Immunother       Date:  2010-09       Impact factor: 4.456

5.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Authors:  Colleen Delaney; Shelly Heimfeld; Carolyn Brashem-Stein; Howard Voorhies; Ronald L Manger; Irwin D Bernstein
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

6.  Transplantation of ex vivo expanded cord blood.

Authors:  Elizabeth J Shpall; Ralph Quinones; Roger Giller; Chan Zeng; Anna E Baron; Roy B Jones; Scott I Bearman; Yago Nieto; Brian Freed; Nancy Madinger; Christopher J Hogan; Vicki Slat-Vasquez; Peggy Russell; Betsy Blunk; Deborah Schissel; Elaine Hild; Janet Malcolm; William Ward; Ian K McNiece
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

7.  Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.

Authors:  M de Lima; J McMannis; A Gee; K Komanduri; D Couriel; B S Andersson; C Hosing; I Khouri; R Jones; R Champlin; S Karandish; T Sadeghi; T Peled; F Grynspan; Y Daniely; A Nagler; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2008-01-21       Impact factor: 5.483

8.  Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

Authors:  Patrick J Hanley; Conrad Russell Young Cruz; Barbara Savoldo; Ann M Leen; Maja Stanojevic; Mariam Khalil; William Decker; Jeffrey J Molldrem; Hao Liu; Adrian P Gee; Cliona M Rooney; Helen E Heslop; Gianpietro Dotti; Malcolm K Brenner; Elizabeth J Shpall; Catherine M Bollard
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

9.  Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.

Authors:  Robert Zeiser; Vu H Nguyen; Andreas Beilhack; Martin Buess; Stephan Schulz; Jeanette Baker; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2006-03-07       Impact factor: 22.113

10.  Ex vivo expansion of natural killer cells for clinical applications.

Authors:  H-G Klingemann; J Martinson
Journal:  Cytotherapy       Date:  2004       Impact factor: 5.414
View more
  6 in total

1.  Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirus.

Authors:  Patrick J Hanley; Sharon Lam; Elizabeth J Shpall; Catherine M Bollard
Journal:  J Vis Exp       Date:  2012-05-07       Impact factor: 1.355

2.  Ex vivo rapamycin treatment of human cord blood CD34+ cells enhances their engraftment of NSG mice.

Authors:  Sara L Rohrabaugh; Timothy B Campbell; Giao Hangoc; Hal E Broxmeyer
Journal:  Blood Cells Mol Dis       Date:  2011-04-15       Impact factor: 3.039

3.  Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia.

Authors:  Juliet N Barker; Mingwei Fei; Chatchada Karanes; Mitchell Horwitz; Steven Devine; Tamila L Kindwall-Keller; Jennifer Holter; Alexia Adams; Brent Logan; Willis H Navarro; Marcie Riches
Journal:  Br J Haematol       Date:  2014-10-01       Impact factor: 6.998

4.  Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization.

Authors:  J Pidala; J Kim; M Schell; S J Lee; R Hillgruber; V Nye; E Ayala; M Alsina; B Betts; R Bookout; H F Fernandez; T Field; F L Locke; T Nishihori; J L Ochoa; L Perez; J Perkins; J Shapiro; C Tate; M Tomblyn; C Anasetti
Journal:  Bone Marrow Transplant       Date:  2012-08-06       Impact factor: 5.483

5.  Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.

Authors:  T L Kindwall-Keller; Y Hegerfeldt; H J Meyerson; S Margevicius; P Fu; W van Heeckeren; H M Lazarus; B W Cooper; S L Gerson; P Barr; W W Tse; C Curtis; L R Fanning; R J Creger; J M Carlson-Barko; M J Laughlin
Journal:  Bone Marrow Transplant       Date:  2011-10-17       Impact factor: 5.483

Review 6.  How to Improve Cord Blood Engraftment?

Authors:  Meral Beksac; Pinar Yurdakul
Journal:  Front Med (Lausanne)       Date:  2016-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.